Takayasu

Takayasu

  
Langford CA et al. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis. Arthritis Rheumatol Hoboken NJ. 2017 Jan 30Lire le résumé
Assad AP et al. Maternal and Neonatal Outcomes in 89 Patients with Takayasu Arteritis (TA): Comparison Before and After the TA Diagnosis. J Rheumatol. 2015 Oct;42(10):1861-4Lire le résumé
Gudbrandsson B et al. Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns. Arthritis Care Res. 2017 Sep;69(9):1384–90.Lire le résumé
Kong X, Sawalha AH. Takayasu arteritis risk locus in IL6 represses the anti-inflammatory gene GPNMB through chromatin looping and recruiting MEF2–HDAC complex. Ann Rheum Dis. oct 2019;78(10):1388 97. (PubMed)Kong X, Sawalha AH. Takayasu arteritis risk locus in IL6 represses the anti-inflammatory gene GPNMB through chromatin looping and recruiting MEF2–HDAC complex. Ann Rheum Dis. oct 2019;78(10):1388 97Lire le résumé
Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, et al. Patterns of Arterial Disease in Takayasu’s Arteritis and Giant Cell Arteritis. Arthritis Care Res [Internet]. 23 août 2019 [cité 15 oct 2019]; Lire le résumé
Michailidou D, Rosenblum JS, Rimland CA, Marko J, Ahlman MA, Grayson PC. Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritis. Ann Rheum Dis. 24 oct 2019;annrheumdis-2019-216145
Lire le résumé
Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology [Internet]. 17 janv 2020 [cité 24 janv 2020]
Lire le résumé
Campochiaro C, Tomelleri A, Sartorelli S, Cavalli G et al. Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis. Semin Arthritis Rheum. 2020 Jan 25Lire le résumé
Cui X, Dai X, Ma L, Yang C, Tan W, Zhang L, et al. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort. Semin Arthritis Rheum. févr 2020;50(1):59‑65Lire le résumé